NewGenIvf Income Before Tax vs Operating Income Analysis
| NIVF Stock | 0.36 0.01 2.86% |
NewGenIvf Group financial indicator trend analysis is infinitely more than just investigating NewGenIvf Group recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NewGenIvf Group is a good investment. Please check the relationship between NewGenIvf Group Income Before Tax and its Operating Income accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewGenIvf Group Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Income Before Tax vs Operating Income
Income Before Tax vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NewGenIvf Group Income Before Tax account and Operating Income. At this time, the significance of the direction appears to have very strong relationship.
The correlation between NewGenIvf Group's Income Before Tax and Operating Income is 0.89. Overlapping area represents the amount of variation of Income Before Tax that can explain the historical movement of Operating Income in the same time period over historical financial statements of NewGenIvf Group Limited, assuming nothing else is changed. The correlation between historical values of NewGenIvf Group's Income Before Tax and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Before Tax of NewGenIvf Group Limited are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Income Before Tax i.e., NewGenIvf Group's Income Before Tax and Operating Income go up and down completely randomly.
Correlation Coefficient | 0.89 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on NewGenIvf Group income statement and is an important metric when analyzing NewGenIvf Group profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Operating Income
Operating Income is the amount of profit realized from NewGenIvf Group operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of NewGenIvf Group Limited is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most indicators from NewGenIvf Group's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NewGenIvf Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewGenIvf Group Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At this time, NewGenIvf Group's Enterprise Value Multiple is most likely to decrease significantly in the upcoming years. The NewGenIvf Group's current Enterprise Value is estimated to increase to about 87.8 M, while Selling General Administrative is projected to decrease to roughly 1.3 M.
| 2010 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 342.5K | 303.9K | 229.7K | 233.7K | Interest Income | 63.0 | 21.0 | 518.0 | 543.9 |
NewGenIvf Group fundamental ratios Correlations
Click cells to compare fundamentals
NewGenIvf Group Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
When determining whether NewGenIvf Group is a strong investment it is important to analyze NewGenIvf Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NewGenIvf Group's future performance. For an informed investment choice regarding NewGenIvf Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewGenIvf Group Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewGenIvf Group. If investors know NewGenIvf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewGenIvf Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NewGenIvf Group is measured differently than its book value, which is the value of NewGenIvf that is recorded on the company's balance sheet. Investors also form their own opinion of NewGenIvf Group's value that differs from its market value or its book value, called intrinsic value, which is NewGenIvf Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewGenIvf Group's market value can be influenced by many factors that don't directly affect NewGenIvf Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewGenIvf Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewGenIvf Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewGenIvf Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.